Get started
Genprex, Inc.Genprex, Inc.Genprex, Inc.

Genprex, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

GNPX chart


Full chart

GNPX upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪7.90 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−11.9167 USD
Net income (FY)
‪−30.86 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪8.27 M‬
Beta (1Y)
−5.09

Employees


Employees (FY)
26
Change (1Y)
−2 −7.14%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.19 M‬ USD

About Genprex, Inc.


Sector
Health Technology
CEO
Ryan M. Confer
Headquarters
Austin
Website
genprex.com
Founded
2009
FIGI
BBG00F7T0157
Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company’s lead product candidate is REQORSA immunogene therapy drug for non-small cell lung cancer. Its other technologies include GPX-002 gene therapy for diabetes, and ONCOPREX nanoparticle delivery system. Genprex was founded by J. Rodney Varner in April 2009 and is headquartered in Austin, TX.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

GNPX news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of GNPX is 0.8900 USD — it has decreased by −0.60% in the past 24 hours. Watch Genprex, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Genprex, Inc. stocks are traded under the ticker GNPX.
GNPX stock has fallen by −9.00% compared to the previous week, the month change is a −19.29% fall, over the last year Genprex, Inc. has showed a −89.89% decrease.
We've gathered analysts' opinions on Genprex, Inc. future price: according to them, GNPX price has a max estimate of 7.50 USD and a min estimate of 7.50 USD. Watch GNPX chart and read a more detailed Genprex, Inc. stock forecast: see what analysts think of Genprex, Inc. and suggest that you do with its stocks.
GNPX reached its all-time high on Apr 30, 2018 with the price of 777.9960 USD, and its all-time low was 0.2806 USD and was reached on Sep 18, 2024. View more price dynamics on GNPX chart.
See other stocks reaching their highest and lowest prices.
GNPX stock is 9.76% volatile and has beta coefficient of −5.09. Track Genprex, Inc. stock price on the chart and check out the list of the most volatile stocks — is Genprex, Inc. there?
Today Genprex, Inc. has the market capitalization of ‪7.90 M‬, it has increased by 11.80% over the last week.
Yes, you can track Genprex, Inc. financials in yearly and quarterly reports right on TradingView.
Genprex, Inc. is going to release the next earnings report on Mar 28, 2025. Keep track of upcoming events with our Earnings Calendar.
GNPX earnings for the last quarter are −1.23 USD per share, whereas the estimation was −1.23 USD resulting in a 0.00% surprise. The estimated earnings for the next quarter are −0.39 USD per share. See more details about Genprex, Inc. earnings.
GNPX net income for the last quarter is ‪−4.32 M‬ USD, while the quarter before that showed ‪−6.50 M‬ USD of net income which accounts for 33.56% change. Track more Genprex, Inc. financial stats to get the full picture.
No, GNPX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 26, 2024, the company has 26.00 employees. See our rating of the largest employees — is Genprex, Inc. on this list?
Like other stocks, GNPX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Genprex, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Genprex, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Genprex, Inc. stock shows the sell signal. See more of Genprex, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.